Global Celiac Drugs Market: Global Market Size, Trends, Competitive, Historical & Forecast Analysis, 2019-2025

Report ID: BMRC 1509 | Number of pages: 194 | Publish Date: Nov 2019 | Publisher: BMRC | Category: Lifesciences and Healthcare
Our final report will cover impact analysis of COVID-19 outbreak
New

The Detailed Market intelligence report on the Global Celiac Drugs Market applies the most effective of each primary and secondary analysis to weighs upon the competitive landscape and also the outstanding market players expected to dominate Global Celiac Drugs Market place for the forecast 2019– 2025.

Celiac disease, also known as celiac sprue or gluten-sensitive enteropathy, is a genetic autoimmune disorder caused due to the body’s inability to process gluten that causes damage to the small intestine. Gluten, a protein found in wheat, barley, and rye, can damage the lining of the small intestine which makes it difficult for the body to absorb nutrients such as iron, fat, calcium, and folate. The immune system mistakes substances inside gluten to be a threat to the body and attacks them, in turn, causing damage to the bowel surface and hampering the body’s ability to absorb nutrition. Digestion problems, dermatitis herpetiformis, abdominal pain, weight loss, musculoskeletal problems, aphthous ulcers, iron deficiency, stunted growth, tingling sensation in the leg, and missed menstrual cycles are some of the symptoms of celiac disease. The disease can lead to various complications and health problems such as miscarriage or infertility, intestinal cancer, osteoporosis, seizures, gall bladder malfunction, neurological manifestation of the disease, stunted growth in children, and birth defects. Celiac disease can also lead to various autoimmune diseases such as lupus, thyroid disease, Sjögren's syndrome, type 1 diabetes, and rheumatoid arthritis. It is difficult to diagnose celiac disease in the initial stages as its symptoms are similar to those of other diseases. Various sensitive and selective blood tests such as anti-tissue transglutaminase antibodies with or without IgA level and IgA anti-endomysial antibodies are used to screen the disease. 

North America dominates the global market for celiac drugs due to rising incidence of celiac disease and lack of treatment options in the region. Asia is expected to show high growth rates in the next five years in global celiac drugs market, with China and India being the fastest growing markets in the Asia-Pacific region. The key driving forces for the celiac drugs market in developing countries are the large pool of patients, increasing awareness about the disease, and rising government funding in the region. 

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Celiac Drugs.

This report studies the global market size of Celiac Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Celiac Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

    ADMA Biologics
    Amgen
    Anthera Pharmaceuticals
    Bayer
    Biogen
    BioLineRx
    Biotest
    Bristol-Myers Squibb
    Celgene
    Celimmune
    F Hoffmann-La Roche
    ImmunogenX
    Immunomedics
    ImmusanT
    Innovate Biopharmaceuticals
    Johnson & Johnson
    Kedrion Biopharma
    LFB Group
    Merck
    Novartis

Market Segment by Product Type

    First Line Of Treatment
    Second Line Of Treatment

Market Segment by Application

    Men
    Women
    Children

Key Regions split in this report: breakdown data for each region.

    United States
    China
    European Union
    Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

    To analyze and research the Celiac Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

    To present the key Celiac Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.

    To split the breakdown data by regions, type, companies and applications

    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

    To identify significant trends, drivers, influence factors in global and regions

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market


Interested in this report?
Get your sample now!
Table of Content
1. Chapter - Report Methodology
1.1. Research Process 
1.2. Primary Research 
1.3. Secondary Research
1.4. Market Size Estimates
1.5. Data Triangulation
1.6. Forecast Model 
1.7. USP’s of Report 
1.8. Report Description 
2. Chapter – Global Celiac Drugs Market Overview: Qualitative Analysis
2.1. Market Introduction
2.2. Executive Summary 
2.3. Global Celiac Drugs Market Classification
2.4. Market Drivers
2.5. Market Restraints
2.6. Market Opportunity
2.7. Celiac Drugs Market: Trends
2.8. Porter’s Five Forces Analysis
2.8.1. Bargaining Power of Suppliers
2.8.2. Bargaining Power of Consumers
2.8.3. Threat of New Entrants
2.8.4. Threat of Substitute Product and Services
2.8.5. Competitive Rivalry within the Industry
2.9. Market Attractiveness Analysis 
2.9.1. Market Attractiveness Analysis by Segmentation 
2.9.2. Market Attractiveness Analysis by Region 
3. Chapter - Global Celiac Drugs Market Overview: Quantitative Analysis
3.1. Global Celiac Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2025
3.2. Global Celiac Drugs Market Revenue Market Share (%), 2014- 2025
3.3. Global Celiac Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate (%), 2014- 2025
3.4. Global Celiac Drugs Market Sales Market Share (%), 2014- 2025
4. Chapter – Global Celiac Drugs Market Analysis: Segmentation By Type
5. Chapter – Global Celiac Drugs Market Analysis: Segmentation By Application
6. Chapter - Global Celiac Drugs Market Analysis: By Manufacturer 
6.1. Global Celiac Drugs Market Revenue (USD Million), by Manufacturer, 2014 - 2025
6.2. Global Celiac Drugs Market Share (%), by Manufacturer, 2018
6.3. Global Celiac Drugs Market Sales (Number of Units), by Manufacturer, 2014 - 2025
6.4. Global Celiac Drugs Market Share (%), by Manufacturer, 2018
6.5. Global Celiac Drugs Market Price (USD/Unit), by Manufacturer, 2014 - 2025
6.6. Global Celiac Drugs Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2025
6.7. Merger & Acquisition
6.8. Collaborations and Partnership
6.9. New Product Launch
7. Chapter –Celiac Drugs Market: Regional Analysis
7.1. North America
7.1.1. North America Celiac Drugs Market Revenue (USD Million) and Growth Rate (%), 2014 – 2025.
7.1.2. North America Celiac Drugs Market Revenue (USD Million) By Country, 2014 – 2025.
7.1.3. North America Celiac Drugs Revenue Market Share (%) By Country, 2014 – 2025.
7.1.4. North America Celiac Drugs Market Revenue (USD Million) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.5. North America Celiac Drugs Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.6. North America Celiac Drugs Market Sales (Number of Units) and Growth Rate (%), 2014 – 2025.
7.1.7. North America Celiac Drugs Market Sales (Number of Units) By Country, 2014 – 2025.
7.1.8. North America Celiac Drugs Sales Market Share (%) By Country, 2014 – 2025.
7.1.9. North America Celiac Drugs Market Sales (Number of Units) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.1.10. North America Celiac Drugs Market Sales (Number of Units), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2025.
7.2. Europe
7.3. Asia Pacific
7.4. Latin America
7.5. Middle East & Africa
8. Chapter - Company Profiles
This free Sample Report is purely a representation of our full report, for evaluating the market scope/data and make informed purchase decisions.